Acupressure for the Treatment of Raynaud's Phenomenon

This study is currently recruiting participants.

Verified February 2013 by University of Michigan

Sponsor:

Information provided by (Responsible Party):

Heather Gladue, DO, University of Michigan

ClinicalTrials.gov Identifier:

NCT01784354

First received: January 18, 2013

Last updated: February 1, 2013

Last verified: February 2013

History of Changes

Purpose

The use of acupressure will be compared to targeted Raynaud's education and will evaluate the` frequency, duration and pain of Raynaud's attacks.

Condition	Intervention
Primary Raynaud's Phenomeon	Other: Acupressure Other: Acupressure dilatation Behavioral: education

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Acupressure in Raynaud's Phenomenon- A Pilot Study.

Further study details as provided by University of Michigan:

Primary Outcome Measures:

Decrease in number of Raynaud's attacks [ Time Frame: 1-2 years ] [ Designated as safety issue: No ]

Estimated Enrollment:	36
Study Start Date:	January 2013
Estimated Study Completion Date:	June 2013
Estimated Primary Completion Date:	June 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Placebo Comparator: Education target education toward Raynaud's	Behavioral: education
Active Comparator: Acupressure acupressure- dilatation	Other: Acupressure dilatation
Active Comparator: Acupressure relaxation acupressure relaxation protocol	Other: Acupressure

Detailed Description:

Using a Raynaud's condition score, severity of tingling, numbness and pain of attacks, the number of attacks and patient and physician visual analog scale we will assess the effect of acupressure.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

> 18 years old
Have Raynauds phenomenon, with at least 4 attacks in the last week
on stable medications
Willing to attend study visits

Exclusion Criteria:

smoker
have a history of stroke, heart attack or irregular heart rhythm
uncontrolled blood pressure
physical or mental illness that would interfere with participating in the study

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01784354

Locations

United States, Michigan
University of Michigan	Recruiting
Ann Arbor, Michigan, United States, 48109
Contact: Jennelle Shaw 734-936-4555 jdsh@med.umich.edu
Principal Investigator: Heather Gladue, DO

Sponsors and Collaborators

University of Michigan

More Information

No publications provided

Responsible Party:	Heather Gladue, DO, Principle Investigator, University of Michigan
ClinicalTrials.gov Identifier:	NCT01784354 History of Changes
Other Study ID Numbers:	HUM00062868
Study First Received:	January 18, 2013
Last Updated:	February 1, 2013
Health Authority:	United States: University of Michigan Institution Review Board

Additional relevant MeSH terms:

Raynaud Disease
Peripheral Vascular Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 23, 2013

To Top